The reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.87BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing P/E
91.81x
vs Health Information Services peers
Updated Jul 18, 2026
Revenue (TTM)
13.65BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Profit Margin
2.27%
vs Health Information Services peers
Updated Jul 18, 2026
Beta
1.79x
vs all stocks
Updated Jul 18, 2026
52-Week Change
258.65%
vs all stocks
Updated Jul 18, 2026
Market Capitalization
13.87BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Enterprise Value
15.84BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing P/E
91.81x
vs Health Information Services peers
Updated Jul 18, 2026
Forward P/E
33.10x
vs Health Information Services peers
Updated Jul 18, 2026
PEG Ratio
0.2374x
vs Health Information Services peers
Updated Jul 18, 2026
Price to Sales (TTM)
1.02x
vs Health Information Services peers
Updated Jul 18, 2026
Price to Book (MRQ)
7.32x
vs Health Information Services peers
Updated Jul 18, 2026
Enterprise to Revenue
1.16x
vs Health Information Services peers
Updated Jul 18, 2026
Enterprise to EBITDA
28.64x
vs Health Information Services peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 30.04×.Updated Jul 18, 2026
Gross Margin
13.34%
vs Health Information Services peers
Updated Jul 18, 2026
Profit Margin
2.27%
vs Health Information Services peers
Updated Jul 18, 2026
Operating Margin
3.36%
vs Health Information Services peers
Updated Jul 18, 2026
Return on Assets (TTM)
4.07%
vs Health Information Services peers
Updated Jul 18, 2026
Return on Equity (TTM)
9.23%
vs Health Information Services peers
Updated Jul 18, 2026
Revenue (TTM)
13.65BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Revenue per Share (TTM)
67.06USDUpdated Jul 18, 2026
Quarterly Revenue Growth
25.60%
vs Health Information Services peers
Updated Jul 18, 2026
Gross Profit (TTM)
1.66BUSD
vs all stocks (USD)
Updated Jul 18, 2026
EBITDA (TTM)
527.17MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Net Income (TTM)
171.04MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Quarterly Earnings Growth (YoY)
403.60%
vs Health Information Services peers
Updated Jul 18, 2026
Operating Cash Flow (TTM)
511.51MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Levered Free Cash Flow (TTM)
1.01BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 18, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Jul 18, 2026
Minority Interest (Equity)
11.30MUSDFY2025 · Dec 31, 2025
Revenue
12.91BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
11.39BUSDFY2025 · Dec 31, 2025
Gross Profit
1.52BUSDFY2025 · Dec 31, 2025
Operating Income
295.25MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
137.94MUSDFY2025 · Dec 31, 2025
Income Tax Expense
33.15MUSDFY2025 · Dec 31, 2025
Net Income
189.11MUSDFY2025 · Dec 31, 2025
EBIT
295.25MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
459.53MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
1.22BUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
157.31MUSDFY2025 · Dec 31, 2025
Net Income from Continuing Operations
189.11MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.55MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
356.57MUSDFY2025 · Dec 31, 2025
Free Cash Flow
261.08MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
88.48MUSDFY2025 · Dec 31, 2025
Income Tax Paid
26.97MUSDFY2025 · Dec 31, 2025
Interest Paid
183.51MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
189.11MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
164.28MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
14.84MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
70.10MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
-550.00KUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-131.29MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
264.17MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-214.10MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-95.48MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-204.56MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-5.03MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-305.08MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-127.12MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-43.17MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-12.85MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-183.15MUSDFY2025 · Dec 31, 2025
Shares Outstanding
193.21MSharesUpdated Jul 18, 2026
Float Shares
176.67MSharesUpdated Jul 18, 2026
Shares Short
12.71MSharesUpdated Jul 18, 2026
Short Ratio
3.03days
vs all stocks
Updated Jul 18, 2026
Short % of Shares Outstanding
10.09%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 6.58%.Updated Jul 18, 2026
% Held by Insiders
3.16%
vs all stocks
Updated Jul 18, 2026
% Held by Institutions
101.50%
vs all stocks
Updated Jul 18, 2026
Total Cash (MRQ)
888.92MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Cash per Share (MRQ)
4.32USDUpdated Jul 18, 2026
Total Debt (MRQ)
2.70BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Debt to Equity (MRQ)
1.36x
vs Health Information Services peers
Updated Jul 18, 2026
Current Ratio (MRQ)
1.74x
vs Health Information Services peers
Updated Jul 18, 2026
Book Value per Share (MRQ)
9.66USDUpdated Jul 18, 2026
Total Assets
6.41BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.89BUSDFY2025 · Dec 31, 2025
Total Liabilities
4.53BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
3.52BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.68BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.85BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
88.37MUSDFY2025 · Dec 31, 2025
Accounts Receivable
989.72MUSDFY2025 · Dec 31, 2025
Inventory
815.18MUSDFY2025 · Dec 31, 2025
Accounts Payable
1.22BUSDFY2025 · Dec 31, 2025
Short-term Debt
102.07MUSDFY2025 · Dec 31, 2025
Deferred Revenue
9.04MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
197.40MUSDFY2025 · Dec 31, 2025
Long-term Debt
2.61BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.46MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
1.92MUSDFY2025 · Dec 31, 2025
Retained Earnings
-74.65MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.89BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
19.01USDUpdated Jul 18, 2026
52-Week High
72.22USDUpdated Jul 18, 2026
52-Week Change
258.65%
vs all stocks
Updated Jul 18, 2026
Beta
1.79x
vs all stocks
Updated Jul 18, 2026
50-Day MA
62.71USDUpdated Jul 18, 2026
200-Day MA
44.37USDUpdated Jul 18, 2026
Avg 10-Day Volume
6.06MSharesUpdated Jul 18, 2026
Avg 30-Day Volume
4.94MSharesUpdated Jul 18, 2026
Diluted EPS (TTM)
0.7700USDUpdated Jul 18, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 13.3%, lower than 95% of its Health Information Services peers (median 62.3%)Significant